 Inside the Issue
|
Health Systems Pharmacy Editor's Note
 - Biosimilars and Health Care Reform
James C. McAllister III, MS, FASHP - Health Care Reform: Funding for Specialty Residencies
James C. McAllister III, MS - Health Systems Pharmacy Editor's Note: Minimizing Prescription Drug Abuse
James C. McAllister III, MS, FASHP - Expanding FDA Regulation of Tobacco Products
James C. McAllister III, MS, FASHP - Supporting Our Professional Associations
James C. McAllister III, MS, FASHP - Educating Our "Captive" Audience About Adherence
James C. McAllister III, MS, FASHP - Promoting Drugs for Unapproved Uses
James C. McAllister III, MS, FASHP - Editor's Note: Regulatory Reform to Eliminate IV Medication Errors?
James C. McAllister III, MS, FASHP - Health Care Reform and Its Impact on Health System Pharmacy
James C. McAllister III, MS, FASHP - Editor's Note: Never Events, Pay-for-Performance, and the Pharmacist's Role
James C. McAllister III, MS, FASHP - Editor's Note: Intravenous Admixture Pharmacists: A Thing of the Past?
James C. McAllister III, MS, FASHP - Editor's Note: Personalizing Medication Errors
James C. McAllister III, MS, FASHP - The Erosion of the Patient?Provider Relationship
James C. McAllister III, MS, FASHP - Editor's Note: Aligning the Practice Community and Academia
James C. McAllister III, MS, FASHP - Editor's Note: Ensuring the Integrity of Purchased Pharmaceuticals
James C. McAllister III, MS, FASHP
|
|
|
|
|
|
